These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 28032312)

  • 21. Circulating microRNAs in heart failure with reduced and preserved left ventricular ejection fraction.
    Wong LL; Armugam A; Sepramaniam S; Karolina DS; Lim KY; Lim JY; Chong JP; Ng JY; Chen YT; Chan MM; Chen Z; Yeo PS; Ng TP; Ling LH; Sim D; Leong KT; Ong HY; Jaufeerally F; Wong R; Chai P; Low AF; Lam CS; Jeyaseelan K; Richards AM
    Eur J Heart Fail; 2015 Apr; 17(4):393-404. PubMed ID: 25619197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combinatorial polymer matrices enhance in vitro maturation of human induced pluripotent stem cell-derived cardiomyocytes.
    Chun YW; Balikov DA; Feaster TK; Williams CH; Sheng CC; Lee JB; Boire TC; Neely MD; Bellan LM; Ess KC; Bowman AB; Sung HJ; Hong CC
    Biomaterials; 2015 Oct; 67():52-64. PubMed ID: 26204225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-mediated maturation of human pluripotent stem cell-derived cardiomyocytes: Towards a better model for cardiotoxicity?
    White MC; Pang L; Yang X
    Food Chem Toxicol; 2016 Dec; 98(Pt A):17-24. PubMed ID: 27265266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maturation-Based Model of Arrhythmogenic Right Ventricular Dysplasia Using Patient-Specific Induced Pluripotent Stem Cells.
    Wen JY; Wei CY; Shah K; Wong J; Wang C; Chen HS
    Circ J; 2015; 79(7):1402-8. PubMed ID: 25971409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelin-1 induces myofibrillar disarray and contractile vector variability in hypertrophic cardiomyopathy-induced pluripotent stem cell-derived cardiomyocytes.
    Tanaka A; Yuasa S; Mearini G; Egashira T; Seki T; Kodaira M; Kusumoto D; Kuroda Y; Okata S; Suzuki T; Inohara T; Arimura T; Makino S; Kimura K; Kimura A; Furukawa T; Carrier L; Node K; Fukuda K
    J Am Heart Assoc; 2014 Nov; 3(6):e001263. PubMed ID: 25389285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNAs in heart failure: is the picture becoming less miRky?
    Melman YF; Shah R; Das S
    Circ Heart Fail; 2014 Jan; 7(1):203-14. PubMed ID: 24449811
    [No Abstract]   [Full Text] [Related]  

  • 27. Mining Exosomal MicroRNAs from Human-Induced Pluripotent Stem Cells-Derived Cardiomyocytes for Cardiac Regeneration.
    Ong SG; Lee WH; Zhou Y; Wu JC
    Methods Mol Biol; 2018; 1733():127-136. PubMed ID: 29435928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent advances in mechanistic studies of heart failure with preserved ejection fraction and its comorbidities-Role of microRNAs.
    Li X; Sun M; Wang Z; Sun S; Wang Y
    Eur J Clin Invest; 2024 Mar; 54(3):e14130. PubMed ID: 38071416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of patient-specific induced pluripotent stem cell-derived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardiomyopathy.
    Ma D; Wei H; Lu J; Ho S; Zhang G; Sun X; Oh Y; Tan SH; Ng ML; Shim W; Wong P; Liew R
    Eur Heart J; 2013 Apr; 34(15):1122-33. PubMed ID: 22798562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GLUT4 expression and glucose transport in human induced pluripotent stem cell-derived cardiomyocytes.
    Bowman PRT; Smith GL; Gould GW
    PLoS One; 2019; 14(7):e0217885. PubMed ID: 31344028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. iPSC-Cardiomyocyte Models of Brugada Syndrome-Achievements, Challenges and Future Perspectives.
    Nijak A; Saenen J; Labro AJ; Schepers D; Loeys BL; Alaerts M
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acellular therapeutic approach for heart failure: in vitro production of extracellular vesicles from human cardiovascular progenitors.
    El Harane N; Kervadec A; Bellamy V; Pidial L; Neametalla HJ; Perier MC; Lima Correa B; Thiébault L; Cagnard N; Duché A; Brunaud C; Lemitre M; Gauthier J; Bourdillon AT; Renault MP; Hovhannisyan Y; Paiva S; Colas AR; Agbulut O; Hagège A; Silvestre JS; Menasché P; Renault NKE
    Eur Heart J; 2018 May; 39(20):1835-1847. PubMed ID: 29420830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Role of Estrogen in Cardiac Metabolism and Diastolic Function.
    Li S; Gupte AA
    Methodist Debakey Cardiovasc J; 2017; 13(1):4-8. PubMed ID: 28413575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modeling Inherited Arrhythmia Disorders Using Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Bezzerides VJ; Zhang D; Pu WT
    Circ J; 2016 Dec; 81(1):12-21. PubMed ID: 27916777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High Glucose Attenuates Anesthetic Cardioprotection in Stem-Cell-Derived Cardiomyocytes: The Role of Reactive Oxygen Species and Mitochondrial Fission.
    Canfield SG; Zaja I; Godshaw B; Twaroski D; Bai X; Bosnjak ZJ
    Anesth Analg; 2016 May; 122(5):1269-79. PubMed ID: 26991754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myocardial Microvascular Inflammatory Endothelial Activation in Heart Failure With Preserved Ejection Fraction.
    Franssen C; Chen S; Unger A; Korkmaz HI; De Keulenaer GW; Tschöpe C; Leite-Moreira AF; Musters R; Niessen HW; Linke WA; Paulus WJ; Hamdani N
    JACC Heart Fail; 2016 Apr; 4(4):312-24. PubMed ID: 26682792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modeling Cardiac Disease Mechanisms Using Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Progress, Promises and Challenges.
    Parrotta EI; Lucchino V; Scaramuzzino L; Scalise S; Cuda G
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How do patients with heart failure with preserved ejection fraction die?
    Chan MM; Lam CS
    Eur J Heart Fail; 2013 Jun; 15(6):604-13. PubMed ID: 23610137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-181c targets Parkin and SMAD7 in human cardiac fibroblasts: Validation of differential microRNA expression in patients with diabetes and heart failure with preserved ejection fraction.
    Jankauskas SS; Mone P; Avvisato R; Varzideh F; De Gennaro S; Salemme L; Macina G; Kansakar U; Cioppa A; Frullone S; Gambardella J; Di Mauro M; Tesorio T; Santulli G
    Mech Ageing Dev; 2023 Jun; 212():111818. PubMed ID: 37116731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heart failure with preserved or reduced ejection fraction in patients treated with peritoneal dialysis.
    Wang AY; Wang M; Lam CW; Chan IH; Lui SF; Sanderson JE
    Am J Kidney Dis; 2013 Jun; 61(6):975-83. PubMed ID: 23474006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.